Z. Shulgau, Y. Kamyshanskiy, and A. Gulyayev, “POSSIBILITIES OF USING MEDICINES AND BIOLOGICALLY ACTIVE SUBSTANCES AS CORRECTIVES FOR THE FORMATION OF PULMONARY FIBROSIS DURING SARS-COV-2 INFECTION AND IN THE POST-COVID PERIOD”, Eurasian Journal of Applied Biotechnology, no. 1, pp. 3–26, Apr. 2023.